Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Over-The-Counter Drug Market Report 2016

  • QYR674796
  • 118 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Over-The-Counter Drug

Revenue, means the sales value of Over-The-Counter Drug

This report studies sales (consumption) of Over-The-Counter Drug in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Bayer HealthCare

GlaxoSmithKline (GSK)

Johnson & Johnson

Pfizer

Sanofi

AstraZeneca

BioGaia

Bristol Myers Squibb

Bukwang Pharmaceutica

Chr. Hansen

Cipla

CoLucid

Daiichi Sankyo

Dr. Reddy's Laboratories

DSM

Eisai

Eli Lilly

EMS

Euradite

Friggs

Genomma Lab Internacional

Glanbia

Herbalife

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Over-The-Counter Drug in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Over-The-Counter Drug Market Report 2016

1 Over-The-Counter Drug Overview

1.1 Product Overview and Scope of Over-The-Counter Drug

1.2 Classification of Over-The-Counter Drug

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Over-The-Counter Drug

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Over-The-Counter Drug (2011-2021)

1.4.1 USA Over-The-Counter Drug Sales and Growth Rate (2011-2021)

1.4.2 USA Over-The-Counter Drug Revenue and Growth Rate (2011-2021)

2 USA Over-The-Counter Drug Competition by Manufacturers

2.1 USA Over-The-Counter Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Over-The-Counter Drug Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Over-The-Counter Drug Average Price by Manufactures (2015 and 2016)

2.4 Over-The-Counter Drug Market Competitive Situation and Trends

2.4.1 Over-The-Counter Drug Market Concentration Rate

2.4.2 Over-The-Counter Drug Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Over-The-Counter Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Over-The-Counter Drug Sales and Market Share by Type (2011-2016)

3.2 USA Over-The-Counter Drug Revenue and Market Share by Type (2011-2016)

3.3 USA Over-The-Counter Drug Price by Type (2011-2016)

3.4 USA Over-The-Counter Drug Sales Growth Rate by Type (2011-2016)

4 USA Over-The-Counter Drug Sales (Volume) by Application (2011-2016)

4.1 USA Over-The-Counter Drug Sales and Market Share by Application (2011-2016)

4.2 USA Over-The-Counter Drug Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Over-The-Counter Drug Manufacturers Profiles/Analysis

5.1 Bayer HealthCare

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Over-The-Counter Drug Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Bayer HealthCare Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 GlaxoSmithKline (GSK)

5.2.2 Over-The-Counter Drug Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 GlaxoSmithKline (GSK) Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Johnson & Johnson

5.3.2 Over-The-Counter Drug Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Johnson & Johnson Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Pfizer

5.4.2 Over-The-Counter Drug Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Pfizer Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Sanofi

5.5.2 Over-The-Counter Drug Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Sanofi Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 AstraZeneca

5.6.2 Over-The-Counter Drug Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 AstraZeneca Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 BioGaia

5.7.2 Over-The-Counter Drug Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 BioGaia Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bristol Myers Squibb

5.8.2 Over-The-Counter Drug Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bristol Myers Squibb Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Bukwang Pharmaceutica

5.9.2 Over-The-Counter Drug Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Bukwang Pharmaceutica Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Chr. Hansen

5.10.2 Over-The-Counter Drug Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Chr. Hansen Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Cipla

5.12 CoLucid

5.13 Daiichi Sankyo

5.14 Dr. Reddy's Laboratories

5.15 DSM

5.16 Eisai

5.17 Eli Lilly

5.18 EMS

5.19 Euradite

5.20 Friggs

5.21 Genomma Lab Internacional

5.22 Glanbia

5.23 Herbalife

6 Over-The-Counter Drug Manufacturing Cost Analysis

6.1 Over-The-Counter Drug Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Over-The-Counter Drug

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Over-The-Counter Drug Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Over-The-Counter Drug Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Over-The-Counter Drug Market Forecast (2016-2021)

10.1 USA Over-The-Counter Drug Sales, Revenue Forecast (2016-2021)

10.2 USA Over-The-Counter Drug Sales Forecast by Type (2016-2021)

10.3 USA Over-The-Counter Drug Sales Forecast by Application (2016-2021)

10.4 Over-The-Counter Drug Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Over-The-Counter Drug

Table Classification of Over-The-Counter Drug

Figure USA Sales Market Share of Over-The-Counter Drug by Type in 2015

Table Application of Over-The-Counter Drug

Figure USA Sales Market Share of Over-The-Counter Drug by Application in 2015

Figure USA Over-The-Counter Drug Sales and Growth Rate (2011-2021)

Figure USA Over-The-Counter Drug Revenue and Growth Rate (2011-2021)

Table USA Over-The-Counter Drug Sales of Key Manufacturers (2015 and 2016)

Table USA Over-The-Counter Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Over-The-Counter Drug Sales Share by Manufacturers

Figure 2016 Over-The-Counter Drug Sales Share by Manufacturers

Table USA Over-The-Counter Drug Revenue by Manufacturers (2015 and 2016)

Table USA Over-The-Counter Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Over-The-Counter Drug Revenue Share by Manufacturers

Table 2016 USA Over-The-Counter Drug Revenue Share by Manufacturers

Table USA Market Over-The-Counter Drug Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Over-The-Counter Drug Average Price of Key Manufacturers in 2015

Figure Over-The-Counter Drug Market Share of Top 3 Manufacturers

Figure Over-The-Counter Drug Market Share of Top 5 Manufacturers

Table USA Over-The-Counter Drug Sales by Type (2011-2016)

Table USA Over-The-Counter Drug Sales Share by Type (2011-2016)

Figure USA Over-The-Counter Drug Sales Market Share by Type in 2015

Table USA Over-The-Counter Drug Revenue and Market Share by Type (2011-2016)

Table USA Over-The-Counter Drug Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Over-The-Counter Drug by Type (2011-2016)

Table USA Over-The-Counter Drug Price by Type (2011-2016)

Figure USA Over-The-Counter Drug Sales Growth Rate by Type (2011-2016)

Table USA Over-The-Counter Drug Sales by Application (2011-2016)

Table USA Over-The-Counter Drug Sales Market Share by Application (2011-2016)

Figure USA Over-The-Counter Drug Sales Market Share by Application in 2015

Table USA Over-The-Counter Drug Sales Growth Rate by Application (2011-2016)

Figure USA Over-The-Counter Drug Sales Growth Rate by Application (2011-2016)

Table Bayer HealthCare Basic Information List

Table Bayer HealthCare Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bayer HealthCare Over-The-Counter Drug Sales Market Share (2011-2016)

Table GlaxoSmithKline (GSK) Basic Information List

Table GlaxoSmithKline (GSK) Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline (GSK) Over-The-Counter Drug Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson Over-The-Counter Drug Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Over-The-Counter Drug Sales Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi Over-The-Counter Drug Sales Market Share (2011-2016)

Table AstraZeneca Basic Information List

Table AstraZeneca Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca Over-The-Counter Drug Sales Market Share (2011-2016)

Table BioGaia Basic Information List

Table BioGaia Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table BioGaia Over-The-Counter Drug Sales Market Share (2011-2016)

Table Bristol Myers Squibb Basic Information List

Table Bristol Myers Squibb Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol Myers Squibb Over-The-Counter Drug Sales Market Share (2011-2016)

Table Bukwang Pharmaceutica Basic Information List

Table Bukwang Pharmaceutica Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bukwang Pharmaceutica Over-The-Counter Drug Sales Market Share (2011-2016)

Table Chr. Hansen Basic Information List

Table Chr. Hansen Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Chr. Hansen Over-The-Counter Drug Sales Market Share (2011-2016)

Table Cipla Basic Information List

Table Cipla Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cipla Over-The-Counter Drug Sales Market Share (2011-2016)

Table CoLucid Basic Information List

Table CoLucid Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table CoLucid Over-The-Counter Drug Sales Market Share (2011-2016)

Table Daiichi Sankyo Basic Information List

Table Daiichi Sankyo Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Daiichi Sankyo Over-The-Counter Drug Sales Market Share (2011-2016)

Table Dr. Reddy's Laboratories Basic Information List

Table Dr. Reddy's Laboratories Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dr. Reddy's Laboratories Over-The-Counter Drug Sales Market Share (2011-2016)

Table DSM Basic Information List

Table DSM Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table DSM Over-The-Counter Drug Sales Market Share (2011-2016)

Table Eisai Basic Information List

Table Eisai Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eisai Over-The-Counter Drug Sales Market Share (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly Over-The-Counter Drug Sales Market Share (2011-2016)

Table EMS Basic Information List

Table EMS Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table EMS Over-The-Counter Drug Sales Market Share (2011-2016)

Table Euradite Basic Information List

Table Euradite Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Euradite Over-The-Counter Drug Sales Market Share (2011-2016)

Table Friggs Basic Information List

Table Friggs Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Friggs Over-The-Counter Drug Sales Market Share (2011-2016)

Table Genomma Lab Internacional Basic Information List

Table Genomma Lab Internacional Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genomma Lab Internacional Over-The-Counter Drug Sales Market Share (2011-2016)

Table Glanbia Basic Information List

Table Glanbia Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Glanbia Over-The-Counter Drug Sales Market Share (2011-2016)

Table Herbalife Basic Information List

Table Herbalife Over-The-Counter Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Table Herbalife Over-The-Counter Drug Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Over-The-Counter Drug

Figure Manufacturing Process Analysis of Over-The-Counter Drug

Figure Over-The-Counter Drug Industrial Chain Analysis

Table Raw Materials Sources of Over-The-Counter Drug Major Manufacturers in 2015

Table Major Buyers of Over-The-Counter Drug

Table Distributors/Traders List

Figure USA Over-The-Counter Drug Production and Growth Rate Forecast (2016-2021)

Figure USA Over-The-Counter Drug Revenue and Growth Rate Forecast (2016-2021)

Table USA Over-The-Counter Drug Production Forecast by Type (2016-2021)

Table USA Over-The-Counter Drug Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390